News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Bodisen Biotech Announces Interim Results for the Six Month Period Ended June 30, 2007
September 28, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SHAANXI, China, Sept. 28, 2007 (PRIME NEWSWIRE) -- Bodisen Biotech, Inc. (the "Company") (Pink Sheets:BBCZ) (LSE:BODI) (website: www.bodisen.com) today announces its interim results for the six month period ended June 30, 2007.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Asia
MORE ON THIS TOPIC
IPOs
UPDATE: MapLight Seeks $227M IPO for Neuropsych Portfolio
October 7, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Beat Out Two Other Metsera Suitors for Takeover
October 7, 2025
·
3 min read
·
Tristan Manalac
Drug pricing
Amgen Hops on DTC Train To Offer Repatha at 60% Discount
October 7, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Most Life Sciences Companies Not Planning New Investments After Tariffs: Report
October 7, 2025
·
3 min read
·
Dan Samorodnitsky